BiotechTube

aerosolized vancomycin or gentamicin

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ventilator Associated Pneumonia

Conditions

Ventilator Associated Pneumonia, Respiratory Infection, Tracheobronchitis

Trial Timeline

Aug 1, 2003 → Sep 1, 2004

NCT ID
NCT00396578

About aerosolized vancomycin or gentamicin

aerosolized vancomycin or gentamicin is a phase 2 stage product being developed by Nektar Therapeutics for Ventilator Associated Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00396578. Target conditions include Ventilator Associated Pneumonia, Respiratory Infection, Tracheobronchitis.

What happened to similar drugs?

2 of 4 similar drugs in Ventilator Associated Pneumonia were approved

Approved (2) Terminated (2) Active (0)
❌Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
❌Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
✅Imipenem + ImipenemMerckApproved
✅Vancomycin + LinezolidPfizerApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00396578Phase 2Completed

Competing Products

9 competing products in Ventilator Associated Pneumonia

See all competitors
ProductCompanyStageHype Score
Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
32
Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + DoripenemJohnson & JohnsonPhase 2
35
Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
32
Imipenem + ImipenemMerckApproved
43
Vancomycin + LinezolidPfizerApproved
43
anidulafunginPfizerPhase 2
27
LinezolidPfizerPre-clinical
18
IC43 + PlaceboValneva SEPhase 2
29
CeftobiproleBasilea PharmaceuticaPhase 1
15